Medicine & Health

A major study in hospital ICUs shows that bathing patients daily with an antimicrobial soap and applying antibiotic ointment in the nose reduced by 44 percent the bloodstream infections caused by dangerous pathogens, including the drug-resistant bacteria MRSA (pictured).

Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar. They analyzed the sweetener sucralose in 17 severely obese people and found it can influence how the body reacts to glucose.

XPRIZE may create an Alzheimer’s XPRIZE to inspire the ingenuity of researchers to take on the daunting task of stopping the disorder. The Alzheimer’s XPRIZE was proposed by a team of experts co-directed by Eric C. Leuthardt.

A new diagnostic test for a worm infection that eventually leads to severe enlargement and deformities of the legs and genitals is far more sensitive than the current test, according to results of a field study in Liberia, in West Africa, led by Washington University researchers, including Kurt Curtis.

Friday, May 17, is National Bike to Work Day. For nearly 20 years, School of Medicine faculty Laura Bierut and Brad Evanoff have been riding their bikes to work. Earlier this week, they rode their tandem bike to the Medical Campus. The two encourage others to ride their bikes to work, too.

Five Washington University scientists, including Jung-Tsung Shen, PhD, recently received Bear Cub grants. The funding helps researchers commercialize their discoveries.

Catherine “Kate” Appleton, MD, discusses her work as a breast cancer radiologist and how her patients, family and mentors have influenced her career.

WUSTL neurologist John C. Morris, MD, has received the Alzheimer’s Association’s Medical and Scientific Award for 2013.

Erin Sanborn, a doctoral student in the School of Medicine’s Program in Occupational Therapy, is the recipient of the 2013 Women in Science Rosalind Kornfeld Leadership Award given by the Academic Women’s Network at the university.

School of Medicine researchers have shown that several markers for presymptomatic Alzheimer’s disease identified in recent years are accurate predictors of Alzheimer’s years before symptoms develop. Catherine Roe, PhD, says researchers found no differences in the accuracy of the biomarkers.